Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

European Commission grants marketing authorization to Abbott's Humira for psoriasis

Dec. 27, 2007

Peplin reports positive results from phase IIa clinical trial of PEP-005 for actinic keratosis

Dec. 17, 2007

Astion Pharma initiates phase III clinical studies of ASF-1057 for seborrheic dermatitis

Dec. 13, 2007

BioLineRx enters license agreement with Innovative Pharmaceutical Concepts for BL-5010

Dec. 13, 2007

New therapeutic option for pruritus reported in recent Janssen patent

Dec. 10, 2007

Centocor and Janssen-Cilag seek approval for ustekinumab from FDA and EMEA

Dec. 5, 2007

AnGes signs licensing agreement with Meyer for NF-kappaB decoy in the U.S. and Europe

Dec. 3, 2007

Recent Gyeongsang National University patent imparts new treatment for skin hyperpigmentation

Nov. 26, 2007

Meyer obtains license from AnGes for NF-kappaB decoy for inflammatory disease

Nov. 23, 2007

Cardium initiates phase IIb MATRIX clinical study of Excellarate for diabetic ulcers

Nov. 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...